...
首页> 外文期刊>The Internet Journal of Ophthalmology and Visual Science >Effective Pupil Dilatation With A Mixture Of 0.75% Tropicamide And 2.5% Phenylephrine: A Randomized Controlled Trial
【24h】

Effective Pupil Dilatation With A Mixture Of 0.75% Tropicamide And 2.5% Phenylephrine: A Randomized Controlled Trial

机译:0.75%Tropicamide和2.5%Phenylephrine混合物的有效瞳孔扩张:随机对照试验。

获取原文
           

摘要

Purpose: To compare the efficacy in pupil dilatation between a mixture containing 0.75% tropicamide and 2.5% phenylephrine and the alternate application of 1% tropicamide and 10% phenylephrine eye drops.Material and Methods : Patients requiring pupil dilatation were randomized to receive one drop of the mixture every 10 min for four times or our standard application of one drop of 1% tropicamide alternating with one drop of 10% phenylephrine every 10 min for two cycles. Pupil size was measured under bright light with the pupil gauge before, and every 5 min after initial application for 40 min. Application of the drops was discontinued once the pupil diameter reached 7 mm. Blood pressure and pulse rate were monitored every 15 min.Results: Of 40 patients (age 57.3±10.9 years, range 35-70 years), 22 were randomized into the mixture group and 18 into the alternate drug group. Baseline pupil sizes were 1.7±0.5 mm in the mixture group and 1.8±0.4 mm in the alternate drug group. The pupils were successfully dilated to 7 mm within 40 min in 17 patients of the mixture group compared to seven patients in the alternate drug group ( P =0.004, Log Rank test). The mean pupil sizes at 40 min were 6.6±0.8 and 6.0±0.9 mm in the mixture and alternate drug groups respectively ( P =0.050, t-test). Blood pressure and pulse rate were stable and similar in both groups.Conclusions: The mixture of 0.75% tropicamide and 2.5% phenylephrine is superior to our standard application of 1% tropicamide alternating with 10% phenylephrine. It provides faster and more successful pupil dilatation within 40 min. Introduction Pupil dilatation is mandatory for thorough indirect ophthalmoscopy. Drugs used to dilate the pupil include parasympatholytic and sympathomimetic agents. We routinely used 1% tropicamide and 10% phenylephrine in our patients for this purpose. The former was instilled followed by the latter 10 min later. This cycle was repeated 10 min after the first one. In case the pupil was not adequately dilated, another cycle of instillation was applied. Occasional adverse drug reactions have been reported with the usage of 10% phenylephrine, and consists of tachycardia, elevated blood pressure and stroke. (1) Sequencing of drugs in this alternate application routine was sometimes confusing in our busy hospital. To address these problems, we prepared a mixture containing 0.75% tropicamide and 2.5% phenylephrine to use as a mydriatric agent. This study evaluated the efficacy in pupil dilatation of this mixture compared to the alternate application of the separate drugs according to our standard practice. Materials and Methods This double-blind randomized controlled trial was approved by the institutional ethical committee. This study was conducted at the outpatient unit, Department of Ophthalmology, government medical college srinagar. Patients requiring pupil dilatation for indirect ophthalmoscopy were enrolled. Exclusion criteria included being younger than 20 years, the presence of posterior synechia, narrow angle or shallow anterior chamber, currently on any miotic drugs, past history of any ocular injuries or intraocular surgeries including laser treatment, current infectious eye diseases, and being diagnosed with arterial hypertension, cardiac diseases or angle closure glaucoma. All participants were informed about the details of the study before signing the consent. Their eyes were inspected to detect the excluding conditions. The sample size was calculated by Query Advisor program. A total number of 40 patients were required to verify that the time spent for pupil dilatation was different between groups by more than 10 min. Poor pupil dilatation is recognized in diabetic patients. The enrolled patients were therefore classified as diabetics or non-diabetics before being allocated to two groups by stratified block randomization. This measure distributed diabetic patients equally into each study group. Sequence of patient allocation was prepared by a c
机译:目的:比较含0.75%托吡卡胺和2.5%苯肾上腺素的混合物和交替使用1%托吡卡胺和10%苯肾上腺素的眼药水在瞳孔扩张中的疗效。材料和方法:要求瞳孔扩张的患者随机接受一滴每10分钟将混合物清洗四次,或者按照我们的标准用法,每10分钟将一滴1%的邻苯二甲酰胺与一滴10%的去氧肾上腺素交替进行两个周期。瞳孔尺寸是在瞳孔规之前和之后的5分钟内于初次使用前40分钟在明亮的光线下测量的。一旦瞳孔直径达到7 mm,便停止滴加液滴。结果:每15分钟监测一次血压和脉搏频率。结果:40例患者(年龄57.3±10.9岁,范围35-70岁)中,有22例被随机分为混合组,另18例被置于替代药物组。混合组的基线瞳孔大小为1.7±0.5 mm,替代药物组的基线瞳孔大小为1.8±0.4 mm。与替代药物组的7名患者相比,混合组的17名患者在40分钟内成功将瞳孔扩大至7 mm(P = 0.004,对数秩检验)。混合组和替代药物组在40分钟时的平均瞳孔大小分别为6.6±0.8和6.0±0.9 mm(P = 0.050,t检验)。两组的血压和脉搏率稳定且相似。结论:0.75%的托尼酰胺和2.5%的去氧肾上腺素的混合物优于我们标准的1%的托尼酰胺和10%的去氧肾上腺素交替使用。它可以在40分钟内更快,更成功地扩大瞳孔。简介对于彻底的间接检眼镜,必须进行瞳孔扩张。用于扩大瞳孔的药物包括副交感神经药和拟交感神经药。为此,我们通常在患者中使用1%的托吡卡胺和10%的去氧肾上腺素。注入前者,随后注入10分钟。在第一个循环后10分钟重复此循环。如果瞳孔没有充分散开,则应用另一个滴注周期。据报道,使用10%的去氧肾上腺素偶尔会引起药物不良反应,包括心动过速,血压升高和中风。 (1)在我们繁忙的医院中,在这种替代应用程序中对药物进行排序有时会令人困惑。为了解决这些问题,我们制备了包含0.75%的托吡卡胺和2.5%的去氧肾上腺素的混合物,以用作延髓制剂。根据我们的标准做法,该研究评估了该混合物在瞳孔扩张中的功效,与单独使用其他药物的交替使用相比。材料和方法这项双盲随机对照试验已获得机构伦理委员会的批准。这项研究是在斯利那加官立医学院眼科门诊进行的。要求间接瞳孔镜进行瞳孔扩张的患者入组。排除标准包括年龄小于20岁,存在后粘连,前角狭窄或前房浅,当前是否使用任何模拟药物,过去是否有眼外伤或眼内手术史,包括激光治疗,当前感染性眼病以及是否被诊断为动脉高血压,心脏病或闭角型青光眼。在签署同意书之前,所有参与者都被告知研究的细节。检查他们的眼睛以检测排除条件。样本大小由Query Advisor程序计算。总共需要40名患者,以验证两组之间瞳孔扩张所花费的时间相差10分钟以上。糖尿病患者中瞳孔扩张不良。因此,在通过分层分组随机分配将患者分为两组之前,将这些入选患者分为糖尿病患者或非糖尿病患者。该方法将糖尿病患者平均分配到每个研究组中。患者分配的顺序由

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号